New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
16:51 EDTNUVANuVasive releases $62.5M from escrow following appeals court ruling
NuVasive announced the release of $62.5M from a restricted escrow account in relation to NuVasive's trademark dispute regarding the NeuroVision trade name. In January 2011, an unfavorable judgment in the amount of $60M plus attorney fees and costs was entered against NuVasive relating to its use of the NeuroVision trade name. NuVasive subsequently entered into an escrow arrangement and transferred $62.5M into a restricted escrow account to secure the judgment. In reversing the judgment against NuVasive, the Ninth Circuit Court of Appeals remanded the case for a new trial and instructed the court to assign a different judge. The plaintiff has not appealed the Court of Appeals' ruling and NuVasive has now secured the release of the $62.5M from the restricted escrow account.
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
12:03 EDTNUVANuVasive CEO news an incremental positive, says Piper Jaffray
Piper Jaffray views NuVasive's naming Greg Lucier as its permanent CEO as an incremental positive despite the executive's lack direct experience in the spine industry. Piper notes its channel checks indicate no meaningful sales force disruption from the CEO transition. It reiterates an Overweight rating on NuVasive with a $56 price target.
10:13 EDTNUVAHigh option volume stocks
High option volume stocks: GFI EAT DSKY CHTR BID ADTN BLMN EXPR YCS NUVA
08:36 EDTNUVANuVasive appoints Gregory Lucier as CEO
Subscribe for More Information
May 14, 2015
13:58 EDTNUVANuVasive initiated with a Market Perform at Northland
Target $46.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use